FGEN(FGEN)
FGEN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $6M | $6M | $6M |
| Low | $6M | $6M | $6M |
| High | $6M | $6M | $6M |
| EBITDA Avg | $-6M | $-6M | $-6M |
| Low | $-6M | $-6M | $-6M |
| High | $-6M | $-6M | $-6M |
| EBIT Avg | $-6M | $-6M | $-6M |
| Low | $-6M | $-6M | $-6M |
| High | $-6M | $-6M | $-6M |
| Net Income Avg | $-54M | $-52M | $-34M |
| Low | $-70M | $-81M | $-35M |
| High | $-26M | $-37M | $-33M |
| EPS Avg | $-11.95 | $-14.65 | $-8.41 |
| Low | $-17.39 | $-20.14 | $-8.59 |
| High | $-6.51 | $-9.16 | $-8.23 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2M | $2M | $2M | $2M | $2M | $2M |
| Low | $2M | $2M | $2M | $2M | $2M | $2M |
| High | $2M | $2M | $2M | $2M | $2M | $2M |
| EBITDA Avg | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M |
| Low | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M |
| High | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M |
| EBIT Avg | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M |
| Low | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M |
| High | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M |
| Net Income Avg | $-18M | $-18M | $-12M | $-16M | $-15M | $-16M |
| Low | $-18M | $-18M | $-12M | $-16M | $-15M | $-16M |
| High | $-18M | $-18M | $-12M | $-16M | $-15M | $-16M |
| EPS Avg | $-4.44 | $-4.40 | $-2.96 | $-3.85 | $-3.82 | $-4.01 |
| Low | $-4.44 | $-4.40 | $-2.96 | $-3.85 | $-3.82 | $-4.01 |
| High | $-4.44 | $-4.40 | $-2.96 | $-3.85 | $-3.82 | $-4.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |